These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2900222)

  • 1. [Carcinoid syndrome with a course of more than 10 years].
    Baur X; Bortsch A; Autenrieth G; Jacob K; Neudert J; Schneider B; Werdan K
    Internist (Berl); 1988 May; 29(5):347-50. PubMed ID: 2900222
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful symptomatic treatment of malignant carcinoid syndrome with the somatostatin analogue SMS 201-995.
    van Houten AA; Nortier JW; Vendrik CP
    Neth J Med; 1988 Apr; 32(3-4):194-8. PubMed ID: 2896307
    [No Abstract]   [Full Text] [Related]  

  • 3. The carcinoid syndrome.
    Oates JA
    N Engl J Med; 1986 Sep; 315(11):702-4. PubMed ID: 2875390
    [No Abstract]   [Full Text] [Related]  

  • 4. An update of lanreotide acetate for treatment of adults with carcinoid syndrome.
    Guadalupe E; Deshpande HA; Stein SM
    Drugs Today (Barc); 2018 Aug; 54(8):457-465. PubMed ID: 30209440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid reversal of carcinoid crisis with a somatostatin analogue.
    Kvols LK; Martin JK; Marsh HM; Moertel CG
    N Engl J Med; 1985 Nov; 313(19):1229-30. PubMed ID: 2865675
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of malignant carcinoid syndrome with a long-acting somatostatin analogue.
    Altman AR; Tschen JA; Rice L
    Arch Dermatol; 1989 Mar; 125(3):394-6. PubMed ID: 2923448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.
    Ahlman H; Ahlund L; Dahlström A; Nilsson O; Skolnik G; Tisell LE; Tylén U
    Br J Cancer; 1987 Dec; 56(6):840-2. PubMed ID: 2893640
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995.
    Wiedenmann B; Räth U; Rädsch R; Becker F; Kommerell B
    Klin Wochenschr; 1988 Jan; 66(2):75-7. PubMed ID: 2894481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carcinoid tumor--diagnostic and therapeutic problems].
    Batowski S; Bielewicz A
    Pol Tyg Lek; 1994 Jun 6-13; 49(23-24):536-7. PubMed ID: 7675710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoid and carcinoid syndrome].
    Sukhareva GV; Khomeriki SG
    Eksp Klin Gastroenterol; 2008; (3):110-9. PubMed ID: 19145891
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carcinoid syndrome. Presentation of a clinical case].
    Archambault A; Palaic D; Perras P; Lamarche J; Laplante L; Laurendeau F; Proulx J; Thibert F
    Union Med Can; 1971 Oct; 100(10):1961-9. PubMed ID: 5142214
    [No Abstract]   [Full Text] [Related]  

  • 12. The carcinoid syndrome.
    Maton PN
    JAMA; 1988 Sep; 260(11):1602-5. PubMed ID: 2457717
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of carcinoid syndrome with ocreotide (SMS-201-995)].
    Rodríguez-García JL; Arechaga S; Fraile G; Serrano M
    Rev Clin Esp; 1992 Jul; 191(3):168. PubMed ID: 1380173
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy.
    Kvols LK
    Am J Med; 1986 Dec; 81(6B):49-55. PubMed ID: 2432781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin, anaesthesia, and the carcinoid syndrome. Peri-operative administration of a somatostatin analogue to suppress carcinoid tumour activity.
    Roy RC; Carter RF; Wright PD
    Anaesthesia; 1987 Jun; 42(6):627-32. PubMed ID: 2887127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide treatment of carcinoid hypertensive crisis.
    Warner RR; Mani S; Profeta J; Grunstein E
    Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinoid syndrome. II. Clinical manifestations, diagnosis, prognosis and treatment].
    Díaz Recasens J; Ruíz Palomo F; Pérez Corral F; Rapado A
    Rev Clin Esp; 1974 Jan; 132(2):91-8. PubMed ID: 4840233
    [No Abstract]   [Full Text] [Related]  

  • 18. Case report--carcinoid syndrome: two case reports from reserve unit.
    Smith DF
    J R Nav Med Serv; 2011; 97(2):66-71. PubMed ID: 22013639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinoid tumors].
    Tóth M; Prónai L; Németh AM; Tulassay Z
    Orv Hetil; 2002 May; 143(19 Suppl):1087-92. PubMed ID: 12063867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Somatostatin analogs in the treatment of carcinoid syndrome: a case report and review of literature].
    Junik R; Kamińska A; Kamiński M; Ruprecht Z
    Pol Arch Med Wewn; 2003 Sep; 110(3):997-1001. PubMed ID: 14699693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.